Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of efficacy and safety of Beraksurf vs Survanta and Curosurf in preterm newborns with respiratory distress syndrome
IRCT20200529047594N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of beractant in respiratory distress syndrome (RDS) (3 arms), sponsored by Iran University of Medical Sciences. Started Jan 2020; status: completed.
02
Drugs
beractant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20200529047594N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200529047594N1.